Pharma Bum (@CaptainTight) header
Pharma Bum (@CaptainTight) profile picture

20+ years in rare disease clinical trials, 2 FDA approvals. Biotech stocks in plain english, no PhD required. Data first, opinions second. Professional Lurker.

California, USA
Joined March 2009
Photo by Pharma Bum (@CaptainTight)Photo by Pharma Bum (@CaptainTight)Photo by Pharma Bum (@CaptainTight)Photo by Pharma Bum (@CaptainTight)Photo by Pharma Bum (@CaptainTight)Photo by Pharma Bum (@CaptainTight)Photo by Pharma Bum (@CaptainTight)Photo by Pharma Bum (@CaptainTight)Photo by Pharma Bum (@CaptainTight)Photo by Pharma Bum (@CaptainTight)
Pharma Bum retweeted
Citadel dumped 94% of its $SPCX position and opened a $221M position in $RKLB 🔥 @grok is Ken Griffin cooking here?
59
45
7
727
111,787
Pharma Bum retweeted
$KURA CEO acquires $1.5 million dollars at open market! $XBI $IBB
3
13
4
50
8,907
Pharma Bum retweeted
$INSM: “Big picture: One of the more bullish mgmt meetings we've had so far at JEF London... we feel good on the $INSM trajectory and not surprised to see market appreciating this today too.”
1
7
27
3,074
Pharma Bum retweeted
Life is short, Enjoy the moment.
111
1,451
88
11,538
1,301,673
This is a very very difficult game that has been on easy mode for years. It quickly shifted to expert mode months ago. Now that the tide has gone out. You see who is swimming naked. The beautiful thing is the quality accounts are beginning to shine. Unfortunately making it seem easy is what appeals to the masses when it’s easy. People dont think in terms of risk/reward. Only reward. Which is what a slot machine player does. You either play this game like a slot machine player or a poker player. There are no long-term successful slot machine players. But there are occasionally some winners! It's very tough to see people being rag dolled by daily price action and having no plan, no thesis. Just gambling and vibes. People have constantly promoted gambling to escape the permanent underclass. The ironic thing is that it sent everyone further into the permanent underclass. Risk management is important. Anyone who was discussing this prior to June was shit on. I was one and and saw it happen to every other person who did. This cycle exposed how many people think like 🤖 and not just retail Most people don't do their own research and they outsource conviction. How do you expect to succeed if you are not on and endless pursuit of getting better and challenging your own assumptions? That's who you're trading against. I see people who mute bears/bulls and I think that's the dumbest thing you can do for yourself. You need to be challenging your own ideas. Confirmation bias is deadly. Maybe I sound like an asshole. But most people who tell it to you straight do right? There is money on the line. This is serious. Hearing fairytales that make you feel better may be nice in the moment, but it hurts much more in the long run. -AC 🕊️
22
40
10
333
41,953
"Being hated by idiots is the price you pay for not being one of them." — Jean Cocteau
116
5,276
238
26,929
486,941
Pharma Bum retweeted
FIVE SIGNS YOU’RE DEALING WITH A TRULY GOOD PERSON: 1. They often like to be alone.
97
1,180
76
14,830
3,391,214
Pharma Bum retweeted
1
1
10
567
Pharma Bum retweeted
Musk buying Twitter, as @AdamSerwer points out, lured conservatives into the trap of thinking that X is real life - and they paid for it. theatlantic.com/ideas/2026/1…
131
1,102
99
6,060
285,399
So lucky we had an AI czar (David's Sack) to look out for China and Russia and his pals
19
26
2
458
17,516
Replying to @financialjuice
He's gone.
1
269
I just learned you can save a gif by holding it down and hitting copy video link… am I the only one?
1,757
2,415
655
46,294
23,341,514
Pharma Bum retweeted
Mike Alfred E. Neumann on $OPEN in March saying its going to $20 -$50 soon.
42
12
2
140
21,581
Pharma Bum retweeted
Review of Guggenheim's 2026-2027 Therapeutics M&A Basket, featuring $VERA, $ABVX, $RYTM, $CGON, $ORKA, $INSM, $COGT, $DYN, $XENE, $CELC, $CGON, $EWTX, $NAMS, $CCCC, $PRAX, and some of my personal favorites $TVTX, $RZLT, & $DNTH.
4
8
63
8,785
New - The longer you lived in Florida, the more likely you were to vote Democratic. 🔴 1-5 yrs R+25 🔵 11-20 yrs D+5 🔵 20+ yrs D+5 NBC exit polls
329
1,803
494
24,263
1,184,300
To all those Republicans who were claiming that Democrats would tank the stock market if they took back the House and Senate: The Dow is up almost 1200 points. 🍿
645
2,183
73
11,592
91,120
Pharma Bum retweeted
These geniuses managed to turn Texas into a blue state
285
3,324
113
28,012
167,179
Pharma Bum retweeted
I hope (and think) we are likely to be entering a prime biotech deal-making spree over the next few months. Pharma valuations have been soaring (and seemingly will continue to do so today), all while quality biotechs that *could* be M&A targets have been relentlessly abused over the last several months. BTW, side note: If you're looking at the $XBI to determine that "Meh, it hasn't actually been that bad for SMID bios. Look at $XBI in the $150s!!!" - you are absolutely missing the true picture of what has been going on....badly. FORGET the $XBI you think you know - that index is long dead, filled with large cap stocks that DO NOT represent what $XBI used to represent. *And* consider the components that have driven *all* of the upside in the biotech indices of late...it has almost exclusively been GARBAGE that has rallied, leveling out the appearance of damage on the surface, all while under the hood the "quality" stuff has been absolutely demolished. Let's review the setup for an M&A frenzy here... ➡️Pharma revenues have been looking great. The cash is there, and the confidence in the business is there. ➡️Pharma stock prices are looking even better, despite what has actually been a pretty abysmal series of high-impact clinical trial failures from pharma since around the middle of this year. ➡️The patent cliffs are still there, largely unaddressed. The biggest in history. ➡️Not only that, but the cliffs are actively steepening, because the revenue streams that have (largely) been driving pharma valuations higher and higher are the very ones that are about to run out...making the need to act and fill those impending gaps even more dire (there is MUCH more for a pharma to defend going toward a patent cliff when their stock is +50% YoY - dire loss of revenue streams is simply not being priced in recently...they have to act the make that an actual reality) ➡️The elections are now out of the way and we basically have the guarantee of gridlock for at least 2 more years (healthcare's absolute favorite setup). ➡️Rates/cost of capital are almost certainly coming down as part of last night's election results ➡️The 2 biggest healthcare conferences of the year happen within the next 3 months, and (hopefully) pharma will be eager to keep their momentum going by having comprehensive plans for how they plan to manage their patent cliffs ready to go for investors by JPM... ➡️All the while, "quality" biotech M&A targets have actually been in a legitimate bear market over recent months (again, SPARE ME with references to $XBI - this is a borderline irrelevant datapoint today). This is perhaps the most interesting facet of the setup to me. It seems that absolutely everything points to a near-term resumption in biotech M&A after a several-month drought, yet the M&A targets continue to price in significant skepticism...This *further* incentives deals to happen, as valuations are quite palatable for pharma. Somehow, pharma's desperation can be fully evident WITHOUT the market eroding their bargaining power by bidding up their M&A targets. Really a wonderful setup for deals IMO. Pharma is flying as high as ever despite many recent clinical-stage setbacks. Gridlock grants them a political tailwind. Their patent cliffs not only draw closer with time, but also steeper with their ever-growing revenues and valuations, which have known expiration dates. All the while, the solution to their problem is no secret: M&A. Yet, the very obvious targets of all these aligning incentives have traded down relentlessly over recent months...Pharma gets the solution to their problems on sale right now despite the fact we all can see they are becoming increasingly mandatory buyers? Let's hope this is the perfect storm for some serious deal making over the next 3-4 months...the setup certainly looks ripe to me! I predict we will see rapid and *sharp* changes in biotech M&A target valuations as soon as we see a couple decent deals take place...Fingers crossed!
17
14
4
240
67,952
I think tonight also kills the Harris 2028 campaign, maybe even the Newsom one as well
665
1,965
726
63,823
2,286,523